ArticleResearch square2022

A single dose ChAdOx1 nCoV-19 vaccine elicits high antibody responses in individuals with prior SARS-CoV-2 infection comparable to that of double dose vaccinated SARS-CoV-2 infection naïve individuals.

Tesfaye Gelanew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.